title: Future prospects for the development of a novel medical therapy for intracranial aneurysm.
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Aoki
mesh_terms: D017542:Aneurysm, Ruptured / Q000517:prevention & control; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D051546:Cyclooxygenase 2 / Q000502:physiology; D015232:Dinoprostone / Q000502:physiology; D004195:Disease Models, Animal; D055808:Drug Discovery / Q000639:trends; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D002532:Intracranial Aneurysm / Q000150:complications / Q000188:drug therapy* / Q000209:etiology* / Q000235:genetics; D008264:Macrophages; D058990:Molecular Targeted Therapy; D016328:NF-kappa B / Q000502:physiology; D058307:Receptors, Prostaglandin E, EP2 Subtype / Q000502:physiology; D013345:Subarachnoid Hemorrhage / Q000209:etiology / Q000517:prevention & control
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D016328:NF-kappa B; C545644:PTGER2 protein, human; D058307:Receptors, Prostaglandin E, EP2 Subtype; D051546:Cyclooxygenase 2; D015232:Dinoprostone